Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HBOT and Risperidone for Autism Spectrum Disorders
NCT03887754Phase 2Completed
- Sponsor
- Minia University
- Start
- Jan 2016
- Primary completion
- Jan 2018
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of risperidone in Autism Spectrum Disorder (ASD), sponsored by Minia University. Started Jan 2016; status: completed.
02
Drugs
risperidone
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT03887754.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03887754.